It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dermal interstitial fluid (ISF) is an underutilized information-rich biofluid potentially useful in health status monitoring applications whose contents remain challenging to characterize. Here, we present a facile microneedle approach for dermal ISF extraction with minimal pain and no blistering for human subjects and rats. Extracted ISF volumes were sufficient for determining transcriptome, and proteome signatures. We noted similar profiles in ISF, serum, and plasma samples, suggesting that ISF can be a proxy for direct blood sampling. Dynamic changes in RNA-seq were recorded in ISF from induced hypoxia conditions. Finally, we report the first isolation and characterization, to our knowledge, of exosomes from dermal ISF. The ISF exosome concentration is 12–13 times more enriched when compared to plasma and serum and represents a previously unexplored biofluid for exosome isolation. This minimally invasive extraction approach can enable mechanistic studies of ISF and demonstrates the potential of ISF for real-time health monitoring applications.
Philip Miller et al. present an approach for extracting dermal interstitial fluid (ISF) using an array of hollow microneedles in a cylindrical substrate that minimizes skin compression and tissue damage. They extract larger volumes of ISF suitable for downstream analyses, compared to previous reports.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Nano and Micro Sensors, Sandia National Laboratories, Albuquerque, USA (GRID:grid.474520.0) (ISNI:0000000121519272)
2 The University of New Mexico, Department of Emergency Medicine, Albuquerque, USA (GRID:grid.266832.b) (ISNI:0000 0001 2188 8502)
3 Excet Inc., Springfield, USA (GRID:grid.452400.7) (ISNI:0000 0004 0459 0394)
4 Research and Technology Directorate, US Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, Edgewood, USA (GRID:grid.418402.b) (ISNI:0000 0000 9091 7592)
5 Systems Biology, Sandia National Laboratories, Livermore, USA (GRID:grid.474523.3) (ISNI:0000000403888279)
6 Biomass Science and Conversion Technology, Sandia National Laboratories, Livermore, USA (GRID:grid.474523.3) (ISNI:0000000403888279)